Abeona Therapeutics Inc. – LSE:0H7R.L

Abeona Therapeutics stock price today

$0.365
-5.28
-93.53%
Financial Health
0
1
2
3
4
5
6
7
8
9

Abeona Therapeutics stock price monthly change

+2.91%
month

Abeona Therapeutics stock price quarterly change

+2.91%
quarter

Abeona Therapeutics stock price yearly change

+10.78%
year

Abeona Therapeutics key metrics

Market Cap
 246.26M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -3.21
Revenue
 N/A
EBITDA
 -47.45M
Income
 -76.65M
Revenue Q/Q
 N/A
Revenue Y/Y
 227.71%
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Abeona Therapeutics stock price history

Abeona Therapeutics stock forecast

Abeona Therapeutics financial statements

Profit Margin

Abeona Therapeutics Inc. (LSE:0H7R.L): Profit margin
Jun 2023 3.5M -16.65M -475.83%
Sep 2023 0 -11.83M
Dec 2023 0 -16.59M
Mar 2024 0 -31.57M
0H7R.L income statement history

Abeona Therapeutics Financials Estimate

Abeona Therapeutics Inc. (LSE:0H7R.L): Analyst Estimates
Dec 2023 0 -16.59M
Mar 2024 0 -31.57M
Oct 2025 3.75M -9.01M -240.38%
Dec 2025 12.75M -3.96M -31.06%

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Debt to Assets

Abeona Therapeutics Inc. (LSE:0H7R.L): Debt to assets
Jun 2023 53550000 44.20M 82.55%
Sep 2023 66087000 44.04M 66.65%
Dec 2023 64001999 49.17M 76.84%
Mar 2024 74828000 83.70M 111.87%
0H7R.L balance sheet history

Cash Flow

Abeona Therapeutics Inc. (LSE:0H7R.L): Cash Flow
Jun 2023 -10.28M 5.21M 6.61M
Sep 2023 -5.74M -18.74M 22.97M
Dec 2023 -9.38M 11.52M 7.61M
Mar 2024 -14.53M -7.81M 25.44M
0H7R.L cash flow history

Abeona Therapeutics alternative data

Abeona Therapeutics
Employees

Abeona Therapeutics Inc. (LSE:0H7R.L): Employee count
Aug 2023 57
Sep 2023 57
Oct 2023 57
Nov 2023 57
Dec 2023 57
Jan 2024 57
Feb 2024 57
Mar 2024 84
Apr 2024 84
May 2024 84
Jun 2024 84
Jul 2024 84

Abeona Therapeutics other data

Frequently Asked Questions (FAQ)

  • What's the price of Abeona Therapeutics stock today?

    One share of Abeona Therapeutics stock can currently be purchased for approximately $0.37.

  • When is Abeona Therapeutics's next earnings date?

    Unfortunately, Abeona Therapeutics's (0H7R.L) next earnings date is currently unknown.

  • Does Abeona Therapeutics pay dividends?

    No, Abeona Therapeutics does not pay dividends.

  • How much money does Abeona Therapeutics make?

    Abeona Therapeutics has a market capitalization of 246.26M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 147.52% to 3.5M US dollars.

  • What is Abeona Therapeutics's stock symbol?

    Abeona Therapeutics Inc. is traded on the LSE under the ticker symbol "0H7R.L".

  • What is Abeona Therapeutics's primary industry?

    Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.

  • How do i buy shares of Abeona Therapeutics?

    Shares of Abeona Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Abeona Therapeutics have?

    As Jul 2024, Abeona Therapeutics employs 84 workers.

  • When Abeona Therapeutics went public?

    Abeona Therapeutics Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.

  • What is Abeona Therapeutics's official website?

    The official website for Abeona Therapeutics is abeonatherapeutics.com.

  • Where are Abeona Therapeutics's headquarters?

    Abeona Therapeutics is headquartered at 1330 Avenue of the Americas, New York, NY.

  • How can i contact Abeona Therapeutics?

    Abeona Therapeutics's mailing address is 1330 Avenue of the Americas, New York, NY and company can be reached via phone at +64 6 813 4701.

Abeona Therapeutics company profile:

Abeona Therapeutics Inc.

abeonatherapeutics.com
Exchange:

LSE

Full time employees:

84

Industry:

Medical - Pharmaceuticals

Sector:

Healthcare

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.

+64 6 813 4701
1330 Avenue of the Americas
New York, NY 10019

:
ISIN: US00289Y2063
CUSIP: 00289Y206